The start-up meeting of Tyroserleutide Phase III clinical trial in the Drum Tower Hospital affiliated to School of Medicine, Nanjing University was successfully held at the conference room 112 at the authority building of the Drum Tower Hospital on 18 November 2011, and relevant experts attended the conference. Our Marketing Managers expressed that we will try our best to assist the related works to get positive development during the whole project process and our medical department also introduced the protocol, operation procedure and standardized procedure of Tyroserleutide Phase III clinical trial. Medpace (the Clinical Research Organization of this clinical trial) also explained Good Clinical Practice rules. The success of this meeting laid a solid foundation for the Phase III clinical research of Tyroserleutide.